FDA Commissioner Gottlieb announced the formation of a new Drug Shortages Task Force. It will be led by Associate Commissioner for Strategic Initiatives Keagan Lenihan. Its goal is to delve more deeply into the reasons why some shortages remain a persistent challenge and look for holistic solutions in addressing the underlying causes. Recently, FDA submitted an annual drug shortages report to Congress.
[membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
